Renal Replacement Therapy in the Pediatric Critical Care Unit

Abstract

Renal replacement therapy is becoming more prevalent in the pediatric intensive care units for a large variety of disease states, including multiorgan dysfunction syndrome, fluid overload, and electrolyte imbalance. Three modalities—continuous renal replacement therapy, hemodialysis, and peritoneal dialysis—are commonly used. When deciding among the three therapies, there are several advantages and disadvantages of each modality that must be considered. This manuscript provides an overview of each modality as well as its pros and cons.

Keywords

continuous renal replacement therapy - hemodialysis - peritoneal dialysis - dialysis modalities

• References

• 1 Boschee ED, Cave DA, Garros D , et al. Indications and outcomes in children receiving renal replacement therapy in pediatric intensive care. J Crit Care 2014; 29 (1) 37-42
• 2 Symons JM, Chua AN, Somers MJ , et al. Demographic characteristics of pediatric continuous renal replacement therapy: a report of the prospective pediatric continuous renal replacement therapy registry. Clin J Am Soc Nephrol 2007; 2 (4) 732-738
• 3 Symons JM, Brophy PD, Gregory MJ , et al. Continuous renal replacement therapy in children up to 10 kg. Am J Kidney Dis 2003; 41 (5) 984-989
• 4 Sohn YB, Paik KH, Cho HY , et al. Continuous renal replacement therapy in neonates weighing less than 3 kg. Korean J Pediatr 2012; 55 (8) 286-292
• 5 Askenazi DJ, Goldstein SL, Koralkar R , et al. Continuous renal replacement therapy for children ≤10 kg: a report from the prospective pediatric continuous renal replacement therapy registry. J Pediatr 2013; 162 (3) 587-592.e3
• 6 Kaneko M, Ogasawara K, Go H, Imamura T, Momoi N, Hosoya M. Continuous hemodialysis therapy for an extremely low-birthweight infant with hyperammonemia. Pediatr Int 2013; 55 (5) 656-658
• 7 Ronco C, Garzotto F, Brendolan A , et al. Continuous renal replacement therapy in neonates and small infants: development and first-in-human use of a miniaturised machine (CARPEDIEM). Lancet 2014; 383 (9931) 1807-1813
• 8 Faas D, Klauwer D, Klaus G, Zerres K, Neuhäuser C, Heckmann M. Long term peritoneal dialysis in an anuric preterm infant—a futile treatment?. Klin Padiatr 2012; 224 (2) 76-79
• 9 Sutherland SM, Zappitelli M, Alexander SR , et al. Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry. Am J Kidney Dis 2010; 55 (2) 316-325
• 10 Foland JA, Fortenberry JD, Warshaw BL , et al. Fluid overload before continuous hemofiltration and survival in critically ill children: a retrospective analysis. Crit Care Med 2004; 32 (8) 1771-1776
• 11 Gillespie RS, Seidel K, Symons JM. Effect of fluid overload and dose of replacement fluid on survival in hemofiltration. Pediatr Nephrol 2004; 19 (12) 1394-1399
• 12 Levy G. Pharmacokinetics in renal disease. Am J Med 1977; 62 (4) 461-465
• 13 Holubek WJ, Hoffman RS, Goldfarb DS, Nelson LS. Use of hemodialysis and hemoperfusion in poisoned patients. Kidney Int 2008; 74 (10) 1327-1334
• 14 Wong KY, Wong SN, Lam SY, Tam S, Tsoi NS. Ammonia clearance by peritoneal dialysis and continuous arteriovenous hemodiafiltration. Pediatr Nephrol 1998; 12 (7) 589-591
• 15 Arbeiter AK, Kranz B, Wingen AM , et al. Continuous venovenous haemodialysis (CVVHD) and continuous peritoneal dialysis (CPD) in the acute management of 21 children with inborn errors of metabolism. Nephrol Dial Transplant 2010; 25 (4) 1257-1265
• 16 Spinale JM, Laskin BL, Sondheimer N, Swartz SJ, Goldstein SL. High-dose continuous renal replacement therapy for neonatal hyperammonemia. Pediatr Nephrol 2013; 28 (6) 983-986
• 17 Boles JM, Dutel JL, Briere J , et al. Acute renal failure caused by extreme hyperphosphatemia after chemotherapy of an acute lymphoblastic leukemia. Cancer 1984; 53 (11) 2425-2429
• 18 Hackbarth R, Bunchman TE, Chua AN , et al. The effect of vascular access location and size on circuit survival in pediatric continuous renal replacement therapy: a report from the PPCRRT registry. Int J Artif Organs 2007; 30 (12) 1116-1121
• 19 Maya ID, Allon M. Outcomes of tunneled femoral hemodialysis catheters: comparison with internal jugular vein catheters. Kidney Int 2005; 68 (6) 2886-2889
• 20 Fernández SN, Santiago MJ, López-Herce J , et al. Citrate anticoagulation for CRRT in children: comparison with heparin. Biomed Res Int 2014; 2014: 786301
• 21 Schilder L, Nurmohamed SA, Bosch FH , et al; CASH study group. Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial. Crit Care 2014; 18 (4) 472
• 22 Davis TK, Neumayr T, Geile K, Doctor A, Hmeil P. Citrate anticoagulation during continuous renal replacement therapy in pediatric critical care. Pediatr Crit Care Med 2014; 15 (5) 471-485
• 23 Wu MY, Hsu YH, Bai CH, Lin YF, Wu CH, Tam KW. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials. Am J Kidney Dis 2012; 59 (6) 810-818
• 24 Hetzel GR, Schmitz M, Wissing H , et al. Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial. Nephrol Dial Transplant 2011; 26 (1) 232-239
• 25 Soltysiak J, Warzywoda A, Kociński B , et al. Citrate anticoagulation for continuous renal replacement therapy in small children. Pediatr Nephrol 2014; 29 (3) 469-475
• 26 Ostermann M, Dickie H, Tovey L, Treacher D. Heparin algorithm for anticoagulation during continuous renal replacement therapy. Crit Care 2010; 14 (3) 419
• 27 Dell'Aquila R, Chiaramonte S, Rodighiero MP , et al. Rational choice of peritoneal dialysis catheter. Perit Dial Int 2007; 27 (Suppl. 02) S119-S125
• 28 van Esch S, Krediet RT, Struijk DG. Prognostic factors for peritonitis outcome. Contrib Nephrol 2012; 178: 264-270
• 29 Burke M, Hawley CM, Badve SV , et al. Relapsing and recurrent peritoneal dialysis-associated peritonitis: a multicenter registry study. Am J Kidney Dis 2011; 58 (3) 429-436
• 30 Davenport A. Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002–2003. Perit Dial Int 2009; 29 (3) 297-302
• 31 Szeto CC, Kwan BC, Chow KM , et al. Repeat peritonitis in peritoneal dialysis: retrospective review of 181 consecutive cases. Clin J Am Soc Nephrol 2011; 6 (4) 827-833
• 32 Fischbach M, Haraldsson B. Dynamic changes of the total pore area available for peritoneal exchange in children. J Am Soc Nephrol 2001; 12 (7) 1524-1529
• 33 Fischbach M, Warady BA. Peritoneal dialysis prescription in children: bedside principles for optimal practice. Pediatr Nephrol 2009; 24 (9) 1633-1642 , quiz 1640, 1642